Related Experiment Videos

Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis

Gregor Dueckers1, Nihal Guellac, Martin Arbogast

  • 1HELIOS Children's Hospital, Krefeld, Germany.

Clinical Immunology (Orlando, Fla.)
|December 14, 2011
PubMed

Insights

Juvenile idiopathic arthritis (JIA) treatment guidelines were developed using expert consensus. The guideline recommends NSAIDs initially, followed by glucocorticoids or methotrexate for unresponsive JIA cases.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Guideline Development
  • Evidence-Based Medicine

Background:

  • Juvenile idiopathic arthritis (JIA) is the most prevalent rheumatic condition in pediatric populations.
  • Immunomodulatory medications are a cornerstone of JIA management.
  • There is a need for standardized, consensus-driven treatment protocols for JIA.

Purpose of the Study:

  • To establish a multidisciplinary, evidence- and consensus-based treatment guideline for juvenile idiopathic arthritis (JIA).
  • To provide clear recommendations for drug therapy, symptomatic, and surgical management of JIA.

Main Methods:

  • Systematic literature analysis and three consensus conferences were conducted.
  • The nominal group technique (NGT) and Delphi method were employed.
  • Multidisciplinary representatives nominated by scientific societies participated.

Main Results:

  • Fifteen statements covering drug therapy, symptomatic, and surgical management were generated.
  • Initial JIA treatment recommendation: NSAIDs.
  • For unresponsive cases, subsequent treatment includes local glucocorticoids and/or methotrexate.

Conclusions:

  • The developed guideline integrates scientific evidence with clinical expertise.
  • These guidelines aim to enhance the quality of care for children and adolescents diagnosed with JIA.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...